JP2021528059A5 - - Google Patents
Info
- Publication number
- JP2021528059A5 JP2021528059A5 JP2020569986A JP2020569986A JP2021528059A5 JP 2021528059 A5 JP2021528059 A5 JP 2021528059A5 JP 2020569986 A JP2020569986 A JP 2020569986A JP 2020569986 A JP2020569986 A JP 2020569986A JP 2021528059 A5 JP2021528059 A5 JP 2021528059A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- comp
- glycosylated
- polysaccharide
- tag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024061674A JP2024079845A (ja) | 2018-06-16 | 2024-04-05 | グリコシル化されたＣｏｍＰピリンバリアント、製造方法及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862685970P | 2018-06-16 | 2018-06-16 | |
| US62/685,970 | 2018-06-16 | ||
| US201862783971P | 2018-12-21 | 2018-12-21 | |
| US62/783,971 | 2018-12-21 | ||
| PCT/US2019/037251 WO2019241672A2 (en) | 2018-06-16 | 2019-06-14 | Glycosylated comp pilin variants, methods of making and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024061674A Division JP2024079845A (ja) | 2018-06-16 | 2024-04-05 | グリコシル化されたＣｏｍＰピリンバリアント、製造方法及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021528059A JP2021528059A (ja) | 2021-10-21 |
| JP2021528059A5 true JP2021528059A5 (enExample) | 2022-06-22 |
Family
ID=68843212
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020569986A Pending JP2021528059A (ja) | 2018-06-16 | 2019-06-14 | グリコシル化されたＣｏｍＰピリンバリアント、製造方法及びその使用 |
| JP2024061674A Pending JP2024079845A (ja) | 2018-06-16 | 2024-04-05 | グリコシル化されたＣｏｍＰピリンバリアント、製造方法及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024061674A Pending JP2024079845A (ja) | 2018-06-16 | 2024-04-05 | グリコシル化されたＣｏｍＰピリンバリアント、製造方法及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11932670B2 (enExample) |
| EP (1) | EP3806881B1 (enExample) |
| JP (2) | JP2021528059A (enExample) |
| AU (1) | AU2019287659B2 (enExample) |
| CA (1) | CA3103474A1 (enExample) |
| ES (1) | ES3051337T3 (enExample) |
| WO (1) | WO2019241672A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10265391B2 (en) | 2015-02-26 | 2019-04-23 | Vaxnewmo Llc | Acinetobacter O-oligosaccharyltransferases and uses thereof |
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| CA3103474A1 (en) | 2018-06-16 | 2019-12-19 | Vaxnewmo Llc | Glycosylated comp pilin variants, methods of making and uses thereof |
| WO2020131236A1 (en) * | 2018-12-21 | 2020-06-25 | Vaxnewmo Llc | O-linked glycosylation recognition motifs |
| BR112022023234A2 (pt) * | 2020-06-25 | 2023-01-03 | Glaxosmithkline Biologicals Sa | Proteínas de exotoxina a modificada |
| WO2022147142A1 (en) * | 2020-12-31 | 2022-07-07 | Vaxnewmo Llc | Klebsiella pneumoniae o-antigen glycosylated proteins and methods of making and uses thereof |
| WO2022232256A1 (en) * | 2021-04-28 | 2022-11-03 | Vaxnewmo Llc | Minimal sequons sufficient for o-linking glycosylation |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010515430A (ja) | 2006-12-13 | 2010-05-13 | ザ・ガバナーズ・オブ・ザ・ユニバーシティ・オブ・アルバータ | タンパク質のｏ−グリコシル化方法およびそのシステム |
| WO2011109600A1 (en) | 2010-03-05 | 2011-09-09 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for modifying the glycosylation pattern of a polypeptide |
| CA2844831A1 (en) | 2011-08-12 | 2013-02-21 | The Governors Of The University Of Alberta | Method of diagnosing bacterial infections using bacterial glycoproteins |
| HK1202896A1 (en) | 2011-11-04 | 2015-10-09 | 康奈尔大学 | A prokaryote-based cell-free system for the synthesis of glycoproteins |
| ES2905107T3 (es) | 2012-10-12 | 2022-04-07 | Glaxosmithkline Biologicals Sa | Procedimientos de modificación de células hospedadoras |
| EP3444352B1 (en) * | 2012-11-07 | 2020-12-16 | GlaxoSmithKline Biologicals SA | Production of recombinant vaccine in e. coli by enzymatic conjugation |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| JP6356229B2 (ja) | 2013-06-04 | 2018-07-11 | アイコン ジェネティクス ゲーエムベーハー | 植物産生糖タンパク質及び組換え糖タンパク質のｎ−グリコシル化部位占有率を調節する方法 |
| EP3193918A4 (en) | 2014-09-18 | 2018-06-20 | University of Maryland, Baltimore | Broad spectrum conjugate vaccine to prevent klebsiella pneumoniae and pseudomonas aeruginosa infections |
| DK3240895T3 (da) | 2014-12-30 | 2022-04-11 | Glaxosmithkline Biologicals Sa | Sammensætninger og fremgangsmåder til proteinglykosylering |
| US10265391B2 (en) | 2015-02-26 | 2019-04-23 | Vaxnewmo Llc | Acinetobacter O-oligosaccharyltransferases and uses thereof |
| JP6968451B2 (ja) | 2017-01-17 | 2021-11-17 | バイオアプリケーションズ インコーポレイテッドBioapplications Inc. | 植物細胞における目的タンパク質の発現のための組換えベクター |
| EP3492481A1 (en) | 2017-11-30 | 2019-06-05 | Vaxxilon AG | Vaccine against klebsiella pneumoniae |
| CA3103474A1 (en) | 2018-06-16 | 2019-12-19 | Vaxnewmo Llc | Glycosylated comp pilin variants, methods of making and uses thereof |
| US20220054632A1 (en) | 2018-12-12 | 2022-02-24 | Glaxosmithkline Biologicals Sa | Modified carrier proteins for o-linked glycosylation |
| WO2020131236A1 (en) | 2018-12-21 | 2020-06-25 | Vaxnewmo Llc | O-linked glycosylation recognition motifs |
-
2019
- 2019-06-14 CA CA3103474A patent/CA3103474A1/en active Pending
- 2019-06-14 WO PCT/US2019/037251 patent/WO2019241672A2/en not_active Ceased
- 2019-06-14 EP EP19820087.5A patent/EP3806881B1/en active Active
- 2019-06-14 ES ES19820087T patent/ES3051337T3/es active Active
- 2019-06-14 JP JP2020569986A patent/JP2021528059A/ja active Pending
- 2019-06-14 US US17/251,994 patent/US11932670B2/en active Active
- 2019-06-14 AU AU2019287659A patent/AU2019287659B2/en active Active
-
2024
- 2024-03-14 US US18/605,436 patent/US12577280B2/en active Active
- 2024-04-05 JP JP2024061674A patent/JP2024079845A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7851988B2 (ja) | 非天然アミノ酸とのポリペプチド抗原接合体 | |
| JP2022514704A5 (enExample) | ||
| CN116209753A (zh) | 肺炎克雷伯氏菌o-抗原疫苗 | |
| HRP20240847T1 (hr) | Novi polisaharid i njegove upotrebe | |
| JP7699543B2 (ja) | Ｏ結合型グリコシル化認識モチーフ | |
| JP7630603B2 (ja) | 出現血清型２４ｆを含む多価肺炎球菌複合糖質ワクチン | |
| JP2023531242A5 (enExample) | ||
| US12290563B2 (en) | Production of E. coli 018 bioconjugates | |
| CN102695791A (zh) | 蛋白质糖基化 | |
| CN113164581A (zh) | 纯化的肺炎链球菌荚膜多糖 | |
| CN115803087A (zh) | 多价疫苗组合物及其用途 | |
| JP5744842B2 (ja) | 髄膜炎菌と肺炎球菌との結合型ワクチン及びそれを使用する方法 | |
| JP7645946B2 (ja) | 肺炎球菌表面タンパク質Ａ（ＰｓｐＡ）の発現 | |
| CN111741765A (zh) | 免疫原性组合物 | |
| JP2024517754A5 (enExample) | ||
| US11097000B2 (en) | Klebsiella pneumoniae capsule polysaccharide vaccines | |
| CN115362177A (zh) | 糖类的纯化 | |
| HUP0700044A2 (en) | Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates | |
| CN120897997A (zh) | 用于生产具有与第二多肽配偶体的异肽键的糖缀合物多肽的组合物和方法以及这些糖缀合物多肽的用途 |